Ozempic and its weight-loss sibling Wegovy have become household names, but the conversation about their side effects is usually either fear-mongering or hand-waving. The reality sits in between: most side effects are predictable, gut-related, and manageable, while a few rare ones genuinely deserve attention. If you want the honest picture — what is common, what is serious, and why any of it happens — this is it.
Ozempic and Wegovy are both brand names for semaglutide, a GLP-1 receptor agonist. Everything below applies to semaglutide generally. We will cover the common effects, the mechanism behind them, the rare-but-serious ones, and the context the clinical trials provide.
The Common Side Effects: It Is Mostly the Gut
By a wide margin, the most common side effects of semaglutide are gastrointestinal: nausea, vomiting, diarrhea, constipation, and abdominal discomfort. In the large STEP and SUSTAIN clinical trials these were the effects reported most often, and they are the reason some people stop treatment. The good news is that they are usually mild to moderate, tend to be worst early on, and often ease as the body adjusts — which is exactly why clinicians increase the dose gradually rather than starting high.
Nausea is the headline complaint. For many it is a passing nuisance during the adjustment period; for a minority it is persistent enough to be a dealbreaker. Constipation and diarrhea frequently trade places. None of this is mysterious once you understand the mechanism.
Why These Effects Happen
Semaglutide works partly by slowing gastric emptying — food stays in your stomach longer, which helps you feel full sooner and for longer. That is a feature, not a bug: it is central to how the drug reduces appetite. But the same slowed digestion is precisely what produces the nausea, early fullness, and bowel changes. In other words, the main side effects and the main benefit come from the same underlying action, which is why they tend to travel together.
The main side effect and the main benefit come from the same action: slowed gastric emptying is what makes you feel full — and what makes you feel nauseous.Why the gut effects are inseparable from the results
The Rare but Serious Ones
Beyond the gut, a smaller set of effects matter more even though they are uncommon. Gallbladder problems, including gallstones, are associated with semaglutide — partly a known consequence of rapid weight loss in general. Pancreatitis is a rare but recognized concern, and persistent severe abdominal pain is the warning sign that warrants immediate medical attention. Gastroparesis (significantly delayed stomach emptying) can occur and, in some cases, be more than transient.
Semaglutide also carries a boxed warning regarding thyroid C-cell tumors, based on findings in rodent studies; it is contraindicated for people with a personal or family history of medullary thyroid carcinoma or MEN2. Whether that rodent signal applies to humans is not established, but the warning is why screening matters. Finally, hypoglycemia is mainly a risk when semaglutide is combined with insulin or sulfonylureas rather than on its own.
“Ozempic Face” and Muscle Loss
Two talked-about effects are really consequences of losing weight fast, not unique drug toxicities. “Ozempic face” — a gaunt, deflated facial look — comes from losing facial fat volume quickly, which we cover in our Ozempic face guide. The other is loss of lean muscle alongside fat, which happens with any rapid weight loss and is why attention to protein and resistance training comes up so often. Neither is a toxic reaction; both are the predictable cost of losing weight quickly, and both are worth planning around. Our what to eat on Ozempic guide addresses the nutrition side.
Putting It in Context
The trial record offers useful perspective. In STEP-1, the landmark obesity trial, semaglutide produced roughly 15% mean body-weight reduction over 68 weeks — and the dropout rate from side effects, while real, was a minority of participants. The honest takeaway is that most people experience manageable gut effects, a minority find them intolerable, and serious events are rare but real. If semaglutide’s side effects are the dealbreaker, our Ozempic alternatives in Canada guide covers other options, and the GLP-1 weight-loss drugs guide maps the whole class.
The Bottom Line
Most semaglutide side effects are gastrointestinal, dose-related, and tend to ease with time and gradual dose increases — they share a root cause with the drug’s appetite-suppressing benefit. The rarer concerns (gallbladder issues, pancreatitis, the thyroid boxed warning) are genuinely serious but uncommon, and the much-discussed “Ozempic face” and muscle loss are really effects of rapid weight loss rather than unique toxicities. Informed expectations and medical supervision are what separate a manageable experience from a miserable one.
Explore the full GLP-1 class, alternatives, and the research behind each compound in the TrueLabs library.
Frequently Asked Questions
What are the most common Ozempic side effects?
Overwhelmingly gastrointestinal: nausea, vomiting, diarrhea, constipation, and abdominal discomfort. These were the effects most frequently reported in the large STEP and SUSTAIN trials. They are usually mild to moderate, tend to be worst early in treatment, and often ease as the body adjusts, which is why doses are increased gradually rather than started high.
Why does Ozempic cause nausea?
Because semaglutide slows gastric emptying, meaning food stays in your stomach longer. That is central to how it reduces appetite and helps you feel full, but the same slowed digestion is what produces nausea and early fullness. In other words, the main side effect and the main benefit come from the same underlying action, which is why they tend to occur together, especially early on.
What are the serious side effects to watch for?
They are uncommon but real: gallbladder problems including gallstones, rare pancreatitis (severe persistent abdominal pain is the warning sign), and significantly delayed stomach emptying. Semaglutide also carries a boxed warning about thyroid C-cell tumors based on rodent studies, making it contraindicated for those with a personal or family history of medullary thyroid cancer or MEN2. Any severe or persistent symptom warrants prompt medical attention.
Is Ozempic face a real side effect?
It is real, but it is not a unique drug toxicity. The gaunt facial look comes from losing facial fat volume quickly, which happens with any rapid weight loss, not from semaglutide specifically. The same goes for loss of lean muscle alongside fat. Both are predictable consequences of fast weight loss and are the reason attention to protein and resistance training comes up so often.
References
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity, STEP-1. New England Journal of Medicine, 2021.
- FDA prescribing information for Ozempic and Wegovy (semaglutide), including boxed warning on thyroid C-cell tumors.
- Reviews on gastrointestinal adverse effects of GLP-1 receptor agonists. Diabetes, Obesity and Metabolism.
This article is informational and summarizes published research. It is not medical advice, a treatment protocol, or dosing guidance. Approved medications should be used only under a licensed clinician, and any research compounds referenced are for laboratory use only. Always consult the current scientific literature and comply with local regulations.